Titan Biotech Limited reported unaudited earnings results for the second quarter and six months ended September 30, 2012. For the quarter, the company reported total income from operations of INR 70,526,000 against INR 51,578,000 for the same period last year. Profit from operation before other income, finance costs and exceptional items was INR 6,239,000 against INR 6,068,000 for the same period last year. Profit before tax was INR 5,560,000 against INR 5,377,000 for the same period last year. Net profit was INR 3,775,000 or INR 0.54 per basic and diluted share against INR 3,877,000 or INR 0.70 per basic and diluted share for the same period last year.

For the six months, the company reported total income from operations of INR 128,267,000 against INR 102,156,000 for the same period last year. Profit from operation before other income, finance costs and exceptional items was INR 11,045,000 against INR 11,774,000 for the same period last year. Profit before tax was INR 10,713,000 against INR 10,402,000 for the same period last year. Net profit was INR 7,178,000 or INR 1.02 per basic and diluted share against INR 7,402,000 or INR 1.34 per basic and diluted share for the same period last year.